WEIGHT MANAGEMENT & TYPE II DIABETES

Embold | D7260C00015

Sponsor: AstraZeneca
This Phase III, randomized, double-blind, placebo-controlled, multicenter study evaluates the efficacy and safety of Elecoglipron in participants with overweight or obesity and Type 2 diabetes.

SELENE 2 | D8750C00012

Sponsor: AstraZeneca
This Phase III, randomized, double-blind, placebo-controlled, multicenter study evaluates the efficacy and safety of AZD6234 in adults with Type 2 diabetes and overweight or obesity.

What Can I Expect if I Enroll?